CPC CLINICAL TRIALS
CPC offers clinical trials in psychiatric disorders that are compatible with our community needs.
Click here to view our past (closed) Clinical Trials.
We are currently enrolling four clinical trials:
New Study: Smoking Cessation Study
New Study: Depression Study
.Memory Impairment Study
(Click Poster for Details or Call 860-886-1508 ext: 31 )
(Click Poster for Details or Call 860-886-1508 ext: 23)
Why should you participate?
People choose clinical trials for different reason:
To help advocate for medicine
Help others
Receiving investigational medication before it is made available to the public
Lack of response to available treatment
Patients who participate generally receive physical examinations, laboratory testing, and ekg testing with no expense to the participant. Participants may also receive monetary compensation for their time and travel. Participation in any clinical research trial is always voluntary. Enrollment:
If you are interested in a particular trial , please contact Michele or Heather either at the phone number listed or by completing a Trial Inquiry Form. Our coordinator will perform a screening assessment over the phone. If you meet the criteria for a particular trial you will be asked to come to CPC at 200 West Town St. Norwich, CT where you can discuss the details of the trial that you are interested in and ask questions . If you choose to participate you will be asked to sign an informed consent form that has been approved by the sponsoring pharmaceutical company and the IRB "Institutional Review Board"
About Investigational Medication:
An investigational drug must go through three phases in order to become approved by the FDA.
Phase I
First trial of medication in humans usually performed in healthy volunteers. CPC does NOT participate in this phase of development.
Phase II
After review in phase I, and concluding the drug is safe to be used in humans, and it is potentially beneficial to participants with particular disease, the FDA may allow the pharmaceutical company to continue in the development of the drug in phase II. Typically, between 50 and 200 patients will receive the investigational drug. These trials usually also have a group of patients called CONTROL who will receive either the standard treatment or Placebo. Patients are assigned to either group at random and neither the physician nor the patient is aware of which group the participant is in.
Phase III
If the FDA is satisfied with the safety and efficacy of the investigational drug and the pharmaceutical company feel their is a reasonable likelihood that it will be beneficial, then the drug is tested in phase III. This is usually conducted at multiple sites and involves hundred to thousands of patients.
Phase IV
These trials are conducted on medication that already has been approved by the FDA and is on the market.
CPC participates in Phase II, III, and IV research.
 full color ad-banner.jpg)
More Clinical Trial Information:
For more information regarding Clinical Trial Participation, please visit: http://www.clinicaltrials.gov/ct2/info/resources
Understanding Clinical Trials
Glossary of Clinical Trials Terms
NIMH - A Participant's Guilde to Mental Health Clinical Trials
(right click to download this pamphlet)
or www.clinicalconnection.com
